[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100537527":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":27,"centralContacts":31,"locations":36,"responsibleParty":52,"collaborators":23,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":23,"eligibilityCriteria":59,"healthyVolunteers":56,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":23,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":38,"whyStopped":23,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"University of Minnesota","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"PENG block and cryoablation","EXPERIMENTAL","Patients undergoing hip fracture repair aged 18-85",[13],"Drug: PENG block and cryoablation",{"label":15,"type":10,"description":11,"interventionNames":16},"fascia iliaca compartment block",[17],"Drug: fascia iliaca compartment block",[19,24],{"type":20,"name":9,"description":21,"armGroupLabels":22,"otherNames":23},"DRUG","will receive an ultrasound guided PENG block with 20 mL of 0.5% bupivacaine followed by cryoablation of the PENG nerves.",[9],null,{"type":20,"name":15,"description":25,"armGroupLabels":26,"otherNames":23},"will receive an ultrasound guided fascia iliaca compartment catheter with initial bolus of 20 mL of 0.5% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour",[15],[28],{"name":29,"affiliation":5,"role":30},"Jason Habeck","PRINCIPAL_INVESTIGATOR",[32],{"name":33,"role":34,"phone":23,"phoneExt":23,"email":35},"Candace Nelson","CONTACT","nelso377@umn.edu",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Minneapolis","Minnesota","55414","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-93.26384,44.97997,{"lat":48,"lon":47},[51],{"name":33,"role":34,"phone":23,"phoneExt":23,"email":23},{"type":53,"investigatorFullName":23,"investigatorTitle":23,"investigatorAffiliation":23,"oldNameTitle":23,"oldOrganization":23},"SPONSOR","100537527","phase-4-comparison-of-cryoablation-of-pericapsular-nerve-group-peng-to-fascia-iliaca-catheter-in-patients-with-a-hip-fracture-100537527",false,"NCT06278987","Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture","Inclusion Criteria:\n\n* Patients undergoing hip fracture repair aged 18-85.\n\nExclusion Criteria:\n\n* Patients who have an exclusion to regional anesthesia.\n* Patients who are pregnant assessed via self-report or pregnancy test if they have taken one.\n* Non-English speakers\n* Patients who already had their fracture repaired\"","ALL","18 Years","85 Years",{"count":64,"type":65},150,"ESTIMATED","INTERVENTIONAL",[68],"PHASE4","The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.",[71],"Hip Fractures",[73],"Hip fractures","2025-11-24",{"date":76,"type":77},"2025-11-25","ACTUAL",{"date":79,"type":77},"2024-10-01",{"date":81,"type":65},"2027-10-01",{"name":5,"class":6},1]